Evidence method
Level · gp.fundamentals.debt_to_revenue
86.07% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
AXSM · Jun 30, 2026
Axsome Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-342360General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.21% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-15.09% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
45.54% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
17.35% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-22.73% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.17% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
12.43% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History5 statesHistory building
Period transition
What moved in the state?
- Previous
- 98.25%
- Current
- 86.07%
- Delta
- -12.18%
- Previous
- 0.06%
- Current
- 0.21%
- Delta
- 0.14%
- Previous
- -10.83%
- Current
- -15.09%
- Delta
- -4.26%
- Previous
- 57.42%
- Current
- 45.54%
- Delta
- -11.87%
- Previous
- 16.48%
- Current
- 17.35%
- Delta
- 0.87%
- Previous
- -33.14%
- Current
- -22.73%
- Delta
- 10.40%
- Previous
- 27.55%
- Current
- 21.17%
- Delta
- -6.38%
- Previous
- 12.26%
- Current
- 12.43%
- Delta
- 0.17%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Axsome Therapeutics, Inc. →Transitioned To · AXSM CAPEX_INTENSITY_INCREASED →Transitioned To · AXSM CASH_GENERATION_DECREASED →Transitioned To · AXSM GROWTH_DECREASED →Transitioned To · AXSM INVENTORY_PRESSURE_INCREASED →Transitioned To · AXSM PROFITABILITY_INCREASED →Transitioned To · AXSM R_AND_D_INTENSITY_DECREASED →Transitioned To · AXSM SBC_INTENSITY_INCREASED →Transitioned To · AXSM Fundamental State →Transitioned To · AXSM BALANCE_SHEET_LEVERAGE_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.